Paranasal sinus mycoses in north India.
Recognizing the high incidence of paranasal sinus mycoses in north India, we analysed retrospectively the clinical, mycological and management aspects of 178 patients with proven disease attending our institute. On the basis of clinical, radiological, histopathological and mycological findings, the patients could be categorized into those with allergic (8), non-invasive (92) and invasive (78) disease types. Bony erosion without mucosal invasion by fungi was seen in 16 patients with non-invasive disease. Young men from rural areas were the most commonly affected. Rhinorrhoea with nasal polyposis (45.8%) and proptosis (46.4%) was the most common presentation. Concurrent involvement of the maxillary and ethmoid sinuses was common in these patients, whereas isolated sphenoid and frontal sinuses were involved in the invasive variety only. Orbital and intracranial extensions were detected in 100% and 13.2%, respectively, of patients with the invasive type of disease. Aspergillus flavus (79.7%) was the most common isolate. Surgical debridement and sinus ventilation were adequate for the effective management of the non-invasive disease. However, adjuvant medical therapy was included in treatment of the semi-invasive and invasive varieties of the disease. Itraconazole was found to be most useful in prevention of recurrence in the invasive type. Mortality was highest (33.3%) among patients with zygomycotic infection. Invasive fungal granuloma with orbital and intra-cranial invasion is a distinct entity in terms of its clinical course and treatment compared with non-invasive fungal sinusitis, and it needs to be treated aggressively with surgical excision and postoperative itraconazole.
Panda
N K
NK
Department of Otolaryngology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma
S C
SC
Chakrabarti
A
A
Mann
S B
SB
D000293:Adolescent; D000328:Adult; D001228:Aspergillosis / Q000382:microbiology; D001231:Aspergillus flavus / Q000302:isolation & purification; D002648:Child; D005260:Female; D006801:Humans; D007194:India; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000145:classification / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D010254:Paranasal Sinus Diseases / Q000145:classification / Q000382:microbiology / Q000473:pathology / Q000628:therapy; D012189:Retrospective Studies; D016896:Treatment Outcome